Kreis Leslie W.

Average Profitability
<0.0001%
Insider Buys Quantity
5
Insider Buys Sum
$2.18M
Insider Sells Quantity
8
Insider Sells Sum
$3.15M

Insider Activity of Kreis Leslie W.

According to the SEC Form 4 filings, Kreis Leslie W., being in a position of

  1. 10 percent owner at Lantern Pharma Inc.,
    оver the last 12 months, has bought 0 shares, and sold 378237 shares for $1.61M,
    over all time since 2022-11-08, has bought 0 shares, and sold 728237 shares for $3.15M.

The largest purchase of all time was on 2022-11-15 and amounted to 1500000 shares of Cognition Therapeutics, Inc. for $1.8M.

The largest sale of all time was on 2022-11-08 and amounted to 350000 shares of Lantern Pharma Inc. for $1.54M.

Biography of Kreis Leslie W.

No biography is available at this moment.

2024-05-24SaleLantern Pharma Inc.
LTRN
10 percent owner
20,000
0.1889%
$6.33$126,600-35.89%
2024-05-23SaleLantern Pharma Inc.
LTRN
10 percent owner
10,000
0.0932%
$6.25$62,500-34.02%
2024-02-29SaleLantern Pharma Inc.
LTRN
10 percent owner
19,703
0.1653%
$4.87$95,954+2.08%
2024-02-28SaleLantern Pharma Inc.
LTRN
10 percent owner
74,297
0.6556%
$4.85$360,340-4.51%
2024-02-27SaleLantern Pharma Inc.
LTRN
10 percent owner
50,000
0.4668%
$4.40$220,000+9.11%
2024-01-17SaleLantern Pharma Inc.
LTRN
10 percent owner
58,889
0.6101%
$4.20$247,334+17.59%
2023-11-29SaleLantern Pharma Inc.
LTRN
10 percent owner
145,348
1.1501%
$3.44$499,997+8.18%
2022-12-12PurchaseIN8bio, Inc.
INAB
director
75,001
0.359%
$2.48$185,912-44.94%
2022-11-28PurchaseCognition Therapeutics, Inc.
CGTX
director
16,064
0.0706%
$2.65$42,565-31.76%
2022-11-16PurchaseCognition Therapeutics, Inc.
CGTX
director
71,000
0.3069%
$1.40$99,400+27.37%
2022-11-15PurchaseCognition Therapeutics, Inc.
CGTX
director
1.5M
5.2511%
$1.20$1.8M+20.34%
2022-11-08SaleLantern Pharma Inc.
LTRN
director
350,000
3.233%
$4.40$1.54M+13.9%
2022-09-28PurchaseIN8bio, Inc.
INAB
25,000
0.1111%
$2.02$50,535-18.57%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.